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Over the past decade, the SAMJ has published many clinical
guidelines for the management of a variety of common chronic
conditions such as hypertension and diabetes. The SAMJ has
sought to ensure that such guidelines as it published were
authoritative by accepting only those that were formulated by
appropriate medical specialty interest groups.
Clinical guidelines are not an exclusively South African
phenomenon. They are undoubtedly more common in
countries such as the UK, the USA, New Zealand and others,
often driven by medical insurance and national health systems
as a means of controlling costs. Writing in the BMJ, Woolf and
colleagues observe that ‘the broad interest in clinical guidelines
that is stretching across Europe, North America, Australia, New
Zealand and Africa has its origin in issues that most healthcare
systems face: rising healthcare costs, fuelled by increased
demand for care, more expensive technologies, and an ageing
population; variations in service delivery among providers,
hospitals, and geographic regions and the presumption that at
least some of this variation stems from inappropriate care,
either overuse or underuse of services; and the intrinsic desire
of healthcare professionals to offer, and of patients to receive,
the best care possible. Clinicians, policy makers, and payers see
guidelines as a tool for making care more consistent and
efficient and for closing the gap between what clinicians do
and what scientific evidence supports’.1
But questions are frequently asked about the purpose, value
and impact of clinical guidelines. For whom are they written?
What assurance is there that they are scientifically sound and
up to date, and that they are not inspired in some subtle way
by the interests of the pharmaceutical industry, or of the
medical insurer? What about the autonomy of the medical
practitioner to determine for himself or herself what treatment
is appropriate in given circumstances? After all, patients with
the same basic medical condition often present in radically
different ways, requiring the practitioner to offer
individualised treatment for which the guidelines may or may
not provide. Then there is the problem of possible lack of
consensus among the specialists themselves regarding the
appropriate approach in the treatment of a given condition: the
SAMJ has a recent example in which the guideline it published
on the use of hormone replacement therapy has been
challenged by a parallel international menopause interest
group on the basis of what appears to be an equally sound but
different interpretation of the studies that ignited the
controversy on this subject.2
Woolf and colleagues, themselves protagonists of clinical
guidelines, nonetheless point out that such guidelines have
potential limitations and harms. ‘The most important limitation
to guidelines is that the recommendations may be wrong (or at
least wrong for individual patients)’.1 The recommendations
may be wrong for a variety of reasons, including the fact that
the evidence may be lacking or controversial. Secondly, they
can be influenced by the biased opinions or the particular
composition of the group putting them together. Thirdly, the
recommended choices may attach greater importance to
controlling costs than to the needs of patients.
These authors further identify as a potential flaw the fact that
recommendations may fail to take due account of the available
evidence, resulting in the promotion of sub-optimal, ineffective
or even harmful practices. ‘Guidelines that are inflexible can
harm by leaving insufficient room for clinicians to tailor care to
patients.’ For this and other reasons, the BMJ currently requires
that, to be accepted for publication, clinical guidelines be
founded on evidence-based practice that relies on systematic
reviews of randomised clinical trials — something the SAMJ is
considering.
Anecdotal evidence in South Africa suggests that clinical
guidelines are unevenly or even infrequently adopted by
practitioners. Certainly, the guidelines to improve obstetric care
and reduce maternal mortality in South African public
hospitals are all too frequently ignored, according to the recent
findings of the ‘Saving Mothers’ task team. In the Netherlands,
Grol and colleagues3 found that the recommendations of
clinical guidelines were followed in 61% of clinical decisions.
Controversial decisions were followed in 35% of decisions, and
recommendations that demanded a change in existing practice
routines were followed in 44% of decisions.
Feder and colleagues4 observe that ‘the development of good
guidelines does not ensure their use in practice’, and that
research shows that ‘relatively passive methods of
disseminating and implementing guidelines — by publication
in professional journals or mailing to targeted healthcare
professionals — rarely leads to changes in professional
behaviour’. 
The Netherlands group recommends that, in order to
improve the adoption of guidelines by the practitioner, the
compilers of clinical guidelines should employ evidence-based
support, use precise definitions of recommended practice, and
test the feasibility and acceptance of recommended guidelines
on focus groups of the targeted users. New Zealand’s Jackson
and St Bartholomew’s Feder5
emphasise the need for guidelines
to be simple, patient-specific and
user-friendly. ‘One of the
cornerstones of evidence-based
practice (and evidence-based
guidelines) is the requirement that
the evidence is relevant to
individual patients’, and is
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